PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

“Skin in a syringe” a step towards a new way to heal burns

2025-08-12
(Press-News.org) Researchers have created what could be called “skin in a syringe”. The gel containing live cells can be 3D printed into a skin transplant, as shown in a study conducted on mice. This technology may lead to new ways to treat burns and severe wounds. The study was led from the Center for Disaster Medicine and Traumatology and Linköping University in Sweden, and has been published in Advanced Healthcare Materials.

As long as we have a healthy skin, we do not give it much thought. However, if we get major wounds or other injuries, it becomes clear that the skin is the body’s protection from the outside world. Helping the body restore the skin barrier after a serious burn can therefore be a matter of life and death.

Large burns are often treated by transplanting a thin layer of the top part of the skin, the epidermis. This is basically composed of a single cell type. Transplanting only this part of the skin leads to severe scarring.

Under the epidermis there is a thicker and more advanced layer of skin called the dermis. It has blood vessels, nerves, hair follicles and other structures necessary for skin function and elasticity. However, transplanting also the dermis is rarely an option, as the procedure leaves a wound as large as the wound to be healed.

The trick is to create new skin that does not become scar tissue but a functioning dermis.

“The dermis is so complicated that we can’t grow it in a lab. We don’t even know what all its components are. That’s why we, and many others, think that we could possibly transplant the building blocks and then let the body make the dermis itself,” says Johan Junker, researcher at the Swedish Center for Disaster Medicine and Traumatology and docent in plastic surgery at Linköping University, who led the study published in Advanced Healthcare Materials.

The most common cell type in the dermis, the connective tissue cell or fibroblast, is easy to remove from the body and grow in a lab. The connective tissue cell also has the advantage of being able to develop into more specialised cell types depending on what is needed. The researchers behind the study provide a scaffold by having the cells grow on tiny, porous beads of gelatine, a substance similar to skin collagen. But a liquid containing these beads poured on a wound will not stay there.

The researchers’ solution to the problem is mixing the gelatine beads with a gel consisting of another body-specific substance, hyaluronic acid. When the beads and gel are mixed, they are connected using what is known as click chemistry. The result is a gel that, somewhat simplified, can be called skin in a syringe.

“The gel has a special feature that means that it becomes liquid when exposed to light pressure. You can use a syringe to apply it to a wound, for example, and once applied it becomes gel-like again. This also makes it possible to 3D print the gel with the cells in it,” says Daniel Aili, professor of molecular physics at Linköping University, who led the study together with Johan Junker.

In the current study, the researchers 3D-printed small pucks that were placed under the skin of mice. The results point to the potential of this technology to be used to grow the patient’s own cells from a minimal skin biopsy, which are then 3D-printed into a graft and applied to the wound.

“We see that the cells survive and it’s clear that they produce different substances that are needed to create new dermis. In addition, blood vessels are formed in the grafts, which is important for the tissue to survive in the body. We find this material very promising,” says Johan Junker.

Blood vessels are key to a variety of applications for engineered tissue-like materials. Scientists can grow cells in three-dimensional materials that can be used to build organoids, i.e. mini versions of organs. But there is a bottleneck as concerns these tissue models; they lack blood vessels to transport oxygen and nutrients to the cells. This means that there is a limit to how large the structures can get before the cells at the centre die from oxygen and nutrient deficiency.

The LiU researchers may be one step closer to solving the problem of blood vessel supply. In another article, also published in Advanced Healthcare Materials, the researchers describe a method for making threads from materials consisting of 98 per cent water, known as hydrogels.

“The hydrogel threads become quite elastic, so we can tie knots on them. We also show that they can be formed into mini-tubes, which we can pump fluid through or have blood vessel cells grow in,” says Daniel Aili.

The mini-tubes, or the perfusable channels as the researchers also call them, open up new possibilities for the development of blood vessels for e.g. organoids.

Lars Kölby, professor of plastic surgery at Sahlgrenska University Hospital in Gothenburg, also participated in the project. The research has received funding from, among others, the Erling-Persson Foundation, the European Research Council (ERC), the Swedish Research Council and the Knut and Alice Wallenberg Foundation.

 

Articles:

Biphasic granular bioinks for biofabrication of high cell density constructs for dermal regeneration, Rozalin Shamasha, Sneha Kollenchery Ramanathan, Kristin Oskarsdotter, Fatemeh Rasti Boroojeni, Aleksandra Zielińska, Sajjad Naeimipour, Philip Lifwergren, Nina Reustle, Lauren Roberts, Annika Starkenberg, Gunnar Kratz, Peter Apelgren, Karin Säljö, Jonathan Rakar, Lars Kölby, Daniel Aili and Johan Junker, (2025), Advanced Healthcare Materials, published 12 June 2025, doi: https://doi.org/10.1002/adhm.202501430 (Open Access)

Printing and rerouting of elastic and protease responsive shape memory hydrogel filaments, Philip Lifwergren, Viktoria Schoen, Sajjad Naeimipour, Lalit Khare, Anna Wunder, Hanna Blom, Jose G. Martinez, Pierfrancesco Pagella, Anders Fridberger, Johan Junker and Daniel Aili, (2025), Advanced Healthcare Materials, published 20 June 2025, doi: https://doi.org/10.1002/adhm.202502262 (Open Access)

END


ELSE PRESS RELEASES FROM THIS DATE:

BTI, Meiogenix and FFAR announce $2 million breakthrough tomato genetics collaboration

2025-08-12
In a landmark $2 million initiative, the Boyce Thompson Institute (BTI) and biotechnology company Meiogenix have launched a collaboration to develop drought- and disease-resistant tomatoes by tapping the genetic power of wild species. The project, funded through a generous Foundation for Food & Agriculture Research (FFAR) Seeding Solutions grant, seeks to ensure a stable tomato supply by leveraging cutting-edge genomics and breeding technologies to address the global threats of environmental stress and ...

Better calibration for cuff-based blood pressure readings

2025-08-12
A study explains why cuff-based blood pressure readings systematically underestimate systolic blood pressure. High blood pressure is the most important risk factor for premature death. Yet the gold standard method for measuring blood pressure, the inflatable cuff, is known to systematically underestimate systolic (maximum) blood pressure and overestimate diastolic (minimum) blood pressure. To measure blood pressure, a cuff is placed around the upper arm and inflated to constrict the brachial artery, collapsing it. The pressure is then ...

The future of ‘personalized’ cancer treatment: Antitumor mRNA-based vaccines

2025-08-12
Gastric cancer is one of the leading causes of cancer-related mortality worldwide, and peritoneal metastasis, wherein the cancer spreads to the peritoneum or the lining of the abdominal cavity, represents the most common form of recurrence after gastric cancer surgery. This form of metastasis is particularly associated with poor survival outcomes, as current first-line treatment options, including anti-PD-1 therapy combined with chemotherapy, have proven ineffective against peritoneal dissemination. Immunotherapy presents an attractive option for tackling this challenging condition—more ...

Common food thickeners – long thought to pass right through us – are actually digested

2025-08-12
It turns out those cellulose-based thickening agents found in common foods can be digested. Researchers at the University of British Columbia have shown that our gut bacteria can feed on these large molecules – something thought to not be possible – thanks to enzymes that normally help us break down dietary fibre. “Researchers assumed that these thickening agents, which are artificial derivatives of natural cellulose, just pass right through the digestive system unaltered,” says Dr. Deepesh Panwar, a postdoctoral fellow ...

Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

2025-08-12
A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown encouraging early results in patients with pancreatic and colorectal cancer, two of the most difficult-to-treat malignancies, according to a study led in part by investigators at the UCLA Health Jonsson Comprehensive Cancer Center. The findings, published in Nature Medicine, show that the vaccine, called ELI-002 2P, can trigger powerful and lasting immune responses and may help prevent or delay cancer recurrence in high-risk patients whose tumors are driven by KRAS ...

New strategy to boost the effect of immunotherapy in the most aggressive form of lung cancer

2025-08-12
Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), according to a multicenter study led by the Hospital del Mar Research Institute, in collaboration with researchers from the CIBERONC cancer research network. The study, published in Cell Reports Medicine, highlights the role of HGF (hepatocyte growth factor)—which is linked to cell proliferation and survival—in the poor prognosis of this disease and its resistance to treatment. The research explores a novel approach that adds a MET inhibitor to standard therapy and demonstrates improved treatment response. Small cell lung cancer is one of the most aggressive ...

Counties with animal feeding operations have more air pollution, less health insurance coverage

2025-08-12
There are more than 15,000 cattle and hog feeding operations in the United States. These operations rear 70% of the country's cattle and 98% of its hogs.  Now, for the first time in the nation's history, we know with certainty where most of them are, thanks to research from the University of Michigan. The research team found that a quarter of the nation's hog and cattle feeding operations  are found in just 30 counties out of more than 3,000 in the United States. Going a step further, the team also found that an air pollutant linked to heart and respiratory issues near these animal feeding operations, ...

Mirror-like graphite films break records in strength and conductivity

2025-08-12
Graphite has attracted global interest due to its unique anisotropic properties, including excellent electrical and thermal conductivity. Widely used as a battery anode material and in applications such as electromagnetic shielding, catalysis, and nuclear technology, graphite remains a critical material in both industrial and research fields. For decades, researchers have sought to produce high-quality artificial graphite with large grains and smooth, layered structures. Conventional methods typically involve high-temperature treatment of polymer ...

AI uncovers new antibiotics in ancient microbes

2025-08-12
They’ve survived for billions of years in boiling acid, deep-sea vents and salt flats. Now, some of Earth’s oldest life forms — microbes called Archaea — are offering a new weapon in the fight against one of today’s most urgent health threats: antibiotic resistance.  In a new study published in Nature Microbiology, researchers at the University of Pennsylvania used artificial intelligence to identify previously unknown compounds in Archaea that could fuel the development ...

AI meets CRISPR for precise gene editing

2025-08-12
A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining cutting-edge genetic engineering with artificial intelligence. This technique opens the door to more accurate modeling of human diseases and lays the groundwork for next-generation gene therapies. Precise and targeted DNA editing by small point mutations as well as the integration of whole genes via CRISPR/Cas technology has great potential for applications in biotechnology and gene therapy. However, it is very important that the so-called “gene scissors” do not cause any unintended ...

LAST 30 PRESS RELEASES:

Pew awards 22 researchers biomedical science grants

5 Pew-Stewart scholars selected to pursue pioneering cancer research

Pew supports 10 Latin American fellows pursuing scientific advances

Portable spectroscopy enables detection of vaginal microbes

Ultrafast untethered levitation device utilized squeeze film for omni-directional transport

Cancer cells can evade anti-cancer drugs by entering and surviving within bone marrow fibroblasts

Clarifying medical images using next-level pixel-particle analogy

What exactly is Long COVID? New UCLA research shows the answer depends on whom you ask

Work impairment and financial outcomes among adults with vs without long COVID

Hospital financial health and provision of obstetric and neonatal intensive care unit services

Studying terrestrial rocks to prepare techniques for Mars

Tiny ants crack the secret to perfect teamwork

Scientists find a microbial molecule that restores liver and gut health

Regulation of the temperature stability in ordered olivine microwave dielectric ceramics with low-loss for dielectric resonant antenna

Core-cladding-like phosphor ceramics wafer: a path to ultra-high luminance

Exercise may slow epigenetic aging

RSNA AI challenge models can independently interpret mammograms

Embargoed study: Breaking the link between alcohol use and pancreatic cancer

Why common blood pressure readings may be misleading – and how to fix them

Neural navigation: FAU engineers, sensing institute map brain’s blood flow

“Skin in a syringe” a step towards a new way to heal burns

BTI, Meiogenix and FFAR announce $2 million breakthrough tomato genetics collaboration

Better calibration for cuff-based blood pressure readings

The future of ‘personalized’ cancer treatment: Antitumor mRNA-based vaccines

Common food thickeners – long thought to pass right through us – are actually digested

Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

New strategy to boost the effect of immunotherapy in the most aggressive form of lung cancer

Counties with animal feeding operations have more air pollution, less health insurance coverage

Mirror-like graphite films break records in strength and conductivity

AI uncovers new antibiotics in ancient microbes

[Press-News.org] “Skin in a syringe” a step towards a new way to heal burns